<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03467035</url>
  </required_header>
  <id_info>
    <org_study_id>201701317A3</org_study_id>
    <nct_id>NCT03467035</nct_id>
  </id_info>
  <brief_title>Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis</brief_title>
  <official_title>Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chun-Hua Wang, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this research grant are to determine the association of hypoxia with the
      severity of osteoporosis in the patients with bronchiectasis and whether the mechanism of
      inflammation is triggered by inflammasones, which makes it more prone to osteoporosis in
      patients with bronchiectasis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      80 patients with proven bronchiectasis, diagnosed by high-resolution computed tomography
      (HRCT), will be recruited from our outpatient clinic of Chang Gung Memorial Hospital with
      written informed consent. Inclusion criteria are: daily sputum &gt; 10 ml; absence of asthma or
      other unstable systemic diseases; and &quot;steady-state&quot; bronchiectasis (&lt; 10% alteration of 24 h
      sputum volume, FEV1, and FVC, and in the absence of deterioration in respiratory symptoms at
      baseline visits). Exclusion criteria include: unreliable clinic attendance; regular user of
      inhaled or oral corticosteroids; history of lung resection and known asthma defined according
      to American Thoracic Society guidelines.

      The lung function and desaturation will be assessed by six-minute walking tests and the
      severity of disease will be evaluated by HRCT scores. Peripheral blood sample (40ml/person)
      is performed to analyze the bone turnover markers and the level of Hif in PBMC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>six minute walk test</measure>
    <time_frame>6 months</time_frame>
    <description>six minute walk test distance</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Bronchiectasis Adult</condition>
  <condition>Osteoporosis, Osteopenia</condition>
  <arm_group>
    <arm_group_label>desaturation</arm_group_label>
    <description>ΔSpO2 &gt;10% or lowest SpO2&lt;90 during baseline six minute walk test
Check serum level of inflammasone, such as IL-1beta, TGF-beta TRT-PCR for PBMC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-desaturation</arm_group_label>
    <description>ΔSpO2 &lt;10% and lowest SpO2&gt;90 during baseline six minute walk test
Check serum level of inflammasone, such as IL-1beta, TGF-beta TRT-PCR for PBMC</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inflammasone</intervention_name>
    <description>Serum level of cytokine and RT-PCR for PBMC</description>
    <arm_group_label>desaturation</arm_group_label>
    <arm_group_label>non-desaturation</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The remaining samples after the completion of this study are deposited in the Human Genome
      Database of Chang Gung Memorial Medical Center _ Linkou __ Chang Gung Memorial Hospital for
      the follow-up study (including gene research) approved by the Human Ethics Committee of the
      Hospital
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        80 adult patients with proven bronchiectasis, diagnosed by high-resolution computed
        tomography (HRCT), will be recruited from our outpatient clinic of Chang Gung Memorial
        Hospital with written informed consent. The inclusion and exclusion criteria are described
        above.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. willing to sign a written consent form

          2. Male and female subjects with bronchiectasis diagnosed by high-resolution computed
             tomography

          3. willing to accept 6-minute exercise pulmonary function test and blood draw

          4. Men and women over the age of 20

          5. Has undergone chest computed tomography and bone density examination in the recent
             five years

        Exclusion Criteria:

          1. pregnant women or lactating women

          2. asthma, lung resection history before the screening period

          3. active Tuberculosis infection

          4. Have received oral steroid treatment within 30 days

          5. current acute attack or clinical symptoms instability of bronchiectasis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun-Hua Wang</last_name>
    <role>Study Director</role>
    <affiliation>Chang Chung Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hung-Yu Huang, MD</last_name>
    <phone>033281200</phone>
    <phone_ext>8470</phone_ext>
    <email>b9202071@cgmh.org.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chun-Hua Wang, MD</last_name>
    <phone>033281200</phone>
    <phone_ext>8468</phone_ext>
    <email>wchunhua@ms7.hinet.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hung-Yu Huang, MD</last_name>
      <phone>033281200</phone>
      <phone_ext>8470</phone_ext>
      <email>b9202071@cgmh.org.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Cole PJ. Inflammation: a two-edged sword--the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6-15. Review.</citation>
    <PMID>3533593</PMID>
  </reference>
  <reference>
    <citation>Arnett TR. Acidosis, hypoxia and bone. Arch Biochem Biophys. 2010 Nov 1;503(1):103-9. doi: 10.1016/j.abb.2010.07.021. Epub 2010 Jul 23. Review.</citation>
    <PMID>20655868</PMID>
  </reference>
  <reference>
    <citation>Utting JC, Flanagan AM, Brandao-Burch A, Orriss IR, Arnett TR. Hypoxia stimulates osteoclast formation from human peripheral blood. Cell Biochem Funct. 2010 Jul;28(5):374-80. doi: 10.1002/cbf.1660.</citation>
    <PMID>20556743</PMID>
  </reference>
  <reference>
    <citation>Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM. Inflammasomes in COPD and neutrophilic asthma. Thorax. 2015 Dec;70(12):1199-201. doi: 10.1136/thoraxjnl-2014-206736. Epub 2015 Oct 22.</citation>
    <PMID>26493990</PMID>
  </reference>
  <reference>
    <citation>Diehl N, Johnson MM. Prevalence of Osteopenia and Osteoporosis in Patients with Noncystic Fibrosis Bronchiectasis. South Med J. 2016 Dec;109(12):779-783.</citation>
    <PMID>27911973</PMID>
  </reference>
  <reference>
    <citation>McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016 Dec;4(12):969-979. doi: 10.1016/S2213-2600(16)30320-4. Epub 2016 Nov 16.</citation>
    <PMID>27864036</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2018</study_first_submitted>
  <study_first_submitted_qc>March 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2018</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chang Gung Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Chun-Hua Wang, MD</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Bronchiectasis</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

